Echocardiography

Cardiac ultrasound uses reflected sound waves (echos) to create images of anatomy inside the body. Echocardiograms are the primary cardiac imaging modality used to assess the heart and diagnose or track cardiac issues. Echo is the gold standard imaging modality to assess the heart, particularly with calculating left ventricular ejection fraction (LVEF), which is a measure of cardiac output. In addition to noninvasive standard transthoracic echo (TTE), invasive transesophgeal echo (TEE) is also used when clearer, more detailed imaging of the heart is needed. Both 3D and 4D echo echo systems are rapidly gaining wider adoption and enable new types of assessments, especially in the structural heart space and in transcatheter procedural guidance. Find news on general ultrasound imaging.

DiA Imaging Analysis, which specialized in developing the AI-based automated cardiac ultrasound solution LVivo Seamless. The technology is now integrated through partnerships with dozens of healthcare vendors, including ScImage, GE Healthcare, Philips Healthcare Konica Minolta and IBM Watson.

ScImage latest vendor to adopt DiA Imaging Analysis AI for echocardiography

Artificial intelligence vendor DiA has emerged as a key third-party provider of AI to larger imaging vendors.

June 7, 2022
Novice medical professionals perform diagnostic quality echocardiograms with AI guidance 

AI helps novice medical assistants perform high-quality echocardiograms

In a blind pilot study, inexperienced users successfully captured images for 100% of patients using AI guidance.

May 27, 2022
Boston Scientific’s EMBOLD Fibered Detachable Coil.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance. 

May 4, 2022
The GE healthcare vScan Air was one of several point of care ultrasound (POCUS) systems on display at the ACC 2022 meeting.

VIDEO: Point-of-care ultrasound systems at ACC 2022

There were several point-of-care ultrasound (POCUS) systems on display by vendors at ACC 2022. Here are two of them. 

May 4, 2022
Researchers are using an intra-atrial shunt to lower pressures between the upper chambers of the heart to relieve symptoms in HFpEF heart failure patients. The novel Noya device uses an RF ablation to cut a hole into the septum and then enlarge it using a stent that can then be removed from the body after the procedure. 

Researchers share first human data on new interventional shunt procedure for HFpEF

The first-in-man study, completed by a team of cardiologists in China, included 10 patients presenting with HFpEF. 

April 7, 2022
As artificial intelligence (AI) adoption expands in radiology, there is growing concern that AI algorithms needs to undergo quality assurance (QA) reviews. How to validate radiology AI? How can you validate medical imaging AI?

AI distinguishes between a heart attack and takotsubo syndrome more accurately than cardiologists

The advanced AI model outperformed a team of cardiologists, delivering a better AUC and overall accuracy. 

March 30, 2022
Electrocardiograms analyzed by AI can offer information about mortality risk.

AI models capable of identifying RV, LV dysfunction in ECGs

Specialists used EHR data, imaging results and natural language processing to bring their advanced AI models to life. 

March 18, 2022
PCI can improve the odds of survival for some ischemic heart failure patients with moderate-to-severe functional mitral regurgitation, according to a new study. Image courtesy of Beaumont Hospital. Interventional cardiology procedure in a cath lab at Beaumont Hospital.

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief. 

March 17, 2022